Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer

@inproceedings{Zwakman2017PerioperativeCI,
  title={Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer},
  author={Nienke Zwakman and Rafli van de Laar and Toon van Gorp and Petra L M Zusterzeel and Marc P M L Snijders and Isabel Ferreira and Leon F A G Massuger and Roy F P M Kruitwagen},
  booktitle={Journal of gynecologic oncology},
  year={2017}
}
OBJECTIVE In patients with advanced stage epithelial ovarian cancer (EOC) the volume of residual tumor after debulking is known as prognostic factor for survival. We wanted to examine the relationship between postoperative decline in serum CA125 and residual disease after cytoreductive surgery and evaluate perioperative changes in serum CA125 levels as predictor for disease-specific survival. METHODS A retrospective study was conducted of patients with FIGO stage IIb-IV EOC treated with… CONTINUE READING
Highly Cited
This paper has 498 citations. REVIEW CITATIONS
6 Citations
20 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Clinical use of cancer biomarkers in epithelial ovarian cancer: updated guidelines from the European group on tumor markers

  • G Sölétormos, MJ Duffy, S Othman Abu Hassan, RH Verheijen, B Tholander, RC JrBast
  • Int J Gynecol Cancer
  • 2016
1 Excerpt

Similar Papers

Loading similar papers…